Pro Re Nata brolucizumab for early onset and treatment-naïve diabetic macular edema: A prospective study.

Alper BilgicLaurent KodjikianAditya SudhalkarJesus Hernan Gonzalez-Cortes Francesc March de RibotRiddhima DeshpandeMartin S SpitzerThibaud Mathis

Published in: European journal of ophthalmology (2024)

Brolucizumab therapy for DME is a safe and effective modality for the treatment of recent DME and has the potential to reduce the number of injections.

Keyphrases

early onset
late onset
combination therapy
climate change
anti inflammatory
ultrasound guided
human health